Baird Maintains Outperform on Concentrix, Lowers Price Target to $40

Benzinga Newsdesk www.benzinga.com Negative 95.0%

Neg 95% Neu 0% Pos 0%

Baird analyst David Koning maintains Concentrix (NASDAQ:CNXC) with a Outperform and lowers the price target from $52 to $40.